Clinical Research Directory
Browse clinical research sites, groups, and studies.
Qishenyiqi Dripping Pill for Coronary Microvascular Disease
Sponsor: Qilu Hospital of Shandong University
Summary
To investigate the efficacy and safety of Qishenyiqi in patients with microvascular angina pectoris. Long-term follow-up of 1 year will be performed to evaluate the effect of Qishenyiqi on coronary flow reserve and adverse cardiovascular events in patients with coronary microvascular disease.
Official title: The Efficacy and Safety of Qishenyiqi Dripping Pill in Patients With Coronary Microvascular Disease
Key Details
Gender
All
Age Range
40 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
162
Start Date
2023-11-08
Completion Date
2026-06-30
Last Updated
2024-11-21
Healthy Volunteers
No
Conditions
Interventions
Qishenyiqi dripping pills 1 bag, three times a day
Qishenyiqi dripping pills, 1 bag once, three times a day, 12 months
Placebo 1 bag, three times a day
Placebo, 1 bag once, three times a day, 12 months
Locations (3)
Qianfoshan Hospital, Shandong University
Jinan, Shandong, China
Qilu Hospital of Shandong University
Jinan, Shandong, China
Jinan Central Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, China